David Johnson, MD, MPH

PGY3 Resident

David grew up in Cary, NC and graduated from Duke University with a B.A. in economics. After working for a year doing clinical research at Emory University in Atlanta, he returned to his home state for medical school and a Master’s in Public Health at UNC Chapel Hill.  In his spare time he enjoys outdoor activities, traveling, Duke sports, grilling and playing drums.

Education

MD Degree: University of North Carolina School of Medicine
MPH Degree: University of North Carolina at Chapel Hill

Honors

Perkins-Burke Global Health Fellowship, University of North Carolina, 2010
John B. Graham Medical Student Research Travel Award, University of North Carolina, 2010
Alpha Omega Alpha, University of North Carolina School of Medicine, 2010

Presentations

David Johnson, Will Kirby, Jed Ferguson, Angela Smith, Jonathan Matthews, Michael Woods, Matthew Nielsen, Mathew Raynor, Raj Pruthi, Eric Wallen. Nutritional predictors for complications following radical cystectomy: an analysis of the American College of Surgeons National Quality Improvement Program. American College of Surgeons Clinical Congress, Washington, DC, October 2013.

David Johnson, Will Kirby, Jed Ferguson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi, Angela Smith, Eric Wallen, Michael Woods. Utilization of preoperative chemotherapy and associated outcomes after radical cystectomy: An analysis of the American College of Surgeons National Quality Improvement Program. American Urological Association Annual Meeting, San Diego, CA, May 2013.

David Johnson, Angela Smith, Josip Vukina, Jed Ferguson, Will Kirby, Mathew Raynor, Michael Woods, Eric Wallen, Raj Pruthi, Matthew Nielsen. Estimating the burden of preoperatively misclassified, surgically removed benign renal masses in the United States: Implications for the current standard of care. American Urological Association Annual Meeting, San Diego, CA, May 2013. 2013 Best of AUA Annual Meeting.

David Johnson, Will Kirby, Jed Ferguson, Angela Smith, Michael Woods, Mathew Raynor, Eric Wallen, Luke Fifer, Raj Pruthi and Matthew Nielsen. Estimating the burden of preoperatively misclassified, surgically removed benign renal masses in the United States: Implications for the current standard of care. Southeastern Section of the American Urological Association Annual Meeting, Williamsburg, VA, March 2013.

David Johnson, Will Kirby, Jed Ferguson, Jonathan Matthews, Matthew Nielsen, Raj Pruthi, Angela Smith, Eric Wallen and Michael Woods. Utilization of preoperative chemotherapy and associated outcomes after radical cystectomy: An analysis of the American College of Surgeons National Surgical Quality Improvement Program. Southeastern Section of the American Urological Association Annual Meeting, Williamsburg, VA, March 2013.

David Johnson, Angela Smith, Raj Pruthi, Culley Carson, Mathew Nielsen, Eric Wallen, Predicting urine culture results in afebrile patients with acute stone disease: The utility of laboratory tests in guiding management.  American Urological Association Annual Meeting, San Francisco, CA, May 2010.

Peer-Reviewed Publications

Johnson, DC, Nielsen ME, Matthews J, Woods ME, Wallen EM, Pruthi RS, Milowski MI, Smith AB. Neoadjuvant Chemotherapy for Bladder Cancer Does Not Increase Risk of Perioperative Morbidity. BJUI Int. Nov 26, 2013 [Epub ahead of print]

Johnson DC, Woods ME, Pruthi RS. Perioperative Chemotherapy: When to Use It, What to Use, and Why. Urol Clin North Am. 2013 May;40(2):183-95.

Johnson DC, Castle E, Pruthi RS, Woods ME. Robotic intracorproeal urinary diversion: Ileal conduit. J Endourol. 2012 Dec;26(12):1566-9.

Johnson DC. Cancer control in Cuba: The national cancer control unit. Lancet Oncol. 2010 Nov;11(11):1024-5.

Book Chapters

Johnson, DC, Pruthi, RS, Woods, ME. (2013) Perioperative Chemotherapy When to Use it, What to Use and Why. in S. S. Chang (Ed.). Diagnosis, Evaluation, and Treatment of Non-Muscle Invasive Bladder Cancer (pp. 183-195). Philadelphia, Pennsylvania: Elsevier.